Protagenic Therapeutics, Inc.\new Current Liabilities
Protagenic Therapeutics, Inc.\new (PTIX) had Current Liabilities of $1.07 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-19
- 2026-06-30: Liabilities, Current $1.07M.
- 2026-03-31: Liabilities, Current $1.03M.
- 2025-12-31: Liabilities, Current $6.82M.
- 2025-09-30: Liabilities, Current $9.70M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.07M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $1.03M 10-Q · filed 2026-08-19 | |
| 2025-12-31 | $6.82M 10-Q · filed 2026-03-09 | |
| 2025-09-30 | $9.70M 10-Q · filed 2025-11-26 | |
| 2025-06-30 | $10.46M 10-QT · filed 2025-09-10 | |
| 2025-03-31 | $5.04M 10-K · filed 2026-08-14 | $1.08M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $942.76K 10-Q · filed 2025-05-13 | |
| 2024-09-30 | $789.32K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $674.56K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $446.10K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $655.25K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.28M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.51M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.25M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $1.12M 10-K/A · filed 2024-05-14 | |
| 2022-09-30 | $553.48K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $463.09K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $783.64K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $799.53K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $724.42K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $602.59K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $650.97K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $655.19K 10-K · filed 2022-04-07 | |
| 2020-09-30 | $712.15K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $799.90K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $824.25K 10-Q · filed 2020-06-18 | |
| 2019-12-31 | $1.20M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $651.03K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $729.24K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $826.60K 10-Q · filed 2019-05-16 | |
| 2018-12-31 | $907.77K 10-K · filed 2020-04-29 | |
| 2018-09-30 | $667.42K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $532.55K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $504.15K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $561.69K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $536.92K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $578.14K 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $592.81K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $684.86K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $648.33K 10-Q · filed 2016-11-17 | |
| 2016-06-30 | $603.10K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $736.03K 10-Q · filed 2016-07-25 | |
| 2015-12-31 | $678.36K 10-K/A · filed 2017-05-08 | $892.00K 10-Q · filed 2016-03-11 |
| 2015-09-30 | $767.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $189.00K 10-Q · filed 2016-03-11 | |
| 2015-03-31 | $602.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $148.23K 8-K/A · filed 2016-07-12 | $589.00K 10-Q · filed 2015-02-06 |
| 2014-09-30 | $435.00K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $141.00K 10-K · filed 2015-09-25 | |
| 2011-09-30 | $18.82M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $15.23M 10-Q/A · filed 2011-09-07 | |
| 2010-12-31 | $10.26M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |